Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Externally-applied medicine for treating shingles and preparation method

A technology of herpes zoster and external medicine, which is applied in the field of pharmaceuticals for the treatment of herpes zoster, can solve the problems of adverse reactions and is not widely used in the treatment of PHN, and achieve the effects of convenient clinical use, improved healing effect, and fast curative effect

Active Publication Date: 2019-08-30
邱清雄
View PDF1 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0003] Herpes zoster and postherpetic neuralgia, Lin Zhimiao et al., Journal of Clinical Dermatology, Volume 39, No. 6, 2010, describes treatment and prevention, which shows that proven effective treatment includes antidepressants, the more effective is amitriptyline, It is a tricyclic antidepressant, which blocks the depression-pain cycle through its antidepressant effect to achieve analgesic effect; anticonvulsant drugs, such as carbamazepine, have an inhibitory effect on high-frequency discharge ion channels, so they are effective for paroxysmal Sharp pain and tingling have obvious effects, but these two types of drugs have obvious adverse reactions, and are not widely used in the treatment of PHN clinically

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Externally-applied medicine for treating shingles and preparation method
  • Externally-applied medicine for treating shingles and preparation method
  • Externally-applied medicine for treating shingles and preparation method

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0026] The production technology of the present invention is simple, first with 500 grams of Wupifeng, 500 grams of Gualou root, 300 grams of Xizhuang, 600 grams of Huoxuedan, 300 grams of Coptis chinensis, add 5 liters of water and fry to form 3.5 liters of water, filter and cool; use 300 grams of turmeric and 300 grams of realgar gram, 200 grams of garcinia cambogia, ground into powder and passed through a 200-mesh sieve, and the resulting powder was added to the decoction and stirred evenly.

Embodiment 2

[0028] In the present invention, 300 grams of Wupifeng, 600 grams of Gualou root, 300 grams of Xizhuang, 500 grams of Huoxuedan, 400 grams of Coptis chinensis and 5 liters of water are used to decoct 3.5 liters of water and cooled; 200 grams of ground powder passed through a 200-mesh sieve, and the resulting powder was added to the decoction and stirred evenly.

Embodiment 3

[0030] In the present invention, 600 grams of Wupifeng, 300 grams of Gualou root, 200 grams of Xizhuang, 800 grams of Huoxue Dan, 200 grams of Coptis chinensis and 5 liters of water are used to decoct 3.5 liters of water and cooled; 300 grams of ground powder passed through a 200-mesh sieve, and the resulting powder was added to the decoction and stirred evenly.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention belongs to a medicament for treating shingles, and particularly relates to an externally-applied medicine for treating shingles and a preparation method. The externally-applied medicinecomprises the following components in parts by weight of 3-6 parts of potentilla kleiniana, 3-6 parts of snakegourd fruit roots, 2-4 parts of prepared radix et rhizoma rhei, 5-8 parts of glechoma longituba, 2-4 parts of rhizoma coptidis, 2-4 parts of turmeric, 2-4 parts of realgar and 1-3 parts of garcinia hanburyi resin. All the components are combined for use to jointly have the effects of clearing away heat, removing toxicity, relieving pain and the like; the medicine disclosed by the invention is convenient in clinical usage, safe and quick in treatment effects, generally, the medicine canrelieve pain when being used the same day, after 3-5 days, a scab can be formed, after 7 days, recovery can be realized, the treatment time seldom exceeds 15 days, the medicine is often used singly,and no western medicines are added.

Description

technical field [0001] The invention belongs to a medicament for treating herpes zoster, in particular to an external medicine for treating herpes zoster and a preparation method. Background technique [0002] Herpes zoster is an acute infectious skin disease caused by the varicella-zoster virus. Chickenpox occurs when children who are not immune to the virus become infected. After being infected, some patients become carriers without symptoms. Due to the neurotropic nature of the virus, it can remain dormant in the neurons of the dorsal root ganglia of the spinal cord for a long time after infection. When the resistance is low or when you are tired, infected, or caught a cold, the virus can grow and multiply again, and move to the skin along the nerve fibers. Intense inflammation of affected nerves and skin. The rash is generally unilateral and distributed according to nerve segments, and consists of clustered herpes, accompanied by pain; the older you are, the more seve...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K36/9066A61P31/22
CPCA61K36/73A61K36/428A61K36/708A61K36/87A61K36/718A61K36/9066A61K33/36A61K36/38A61K36/74A61K36/53A61K36/80A61K36/41A61K36/704A61K36/185A61K9/0014A61P31/22A61K2236/331A61K2300/00Y02A50/30
Inventor 邱清雄邱舟琪
Owner 邱清雄
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products